Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Microcap & Penny Stocks : Tokyo Joe's Cafe / Anything goes -- Ignore unavailable to you. Want to Upgrade?

To: formerposter who wrote (30597)	8/20/1998 10:02:00 AM
From: Kevin Clarke	Read Replies (1) \| Respond to of 34592

CHECKOUT THIS NEWS STORY....NEW DRUG KILLS HIV VIRUS Wednesday August 19, 10:32 pm Eastern Time Company Press Release SOURCE: Medical Discoveries, Inc. MDI Announces Promising Results on Anti-HIV Activity of Its Novel Drug LAYTON, Utah, Aug. 20 /PRNewswire/ -- Medical Discoveries, Inc. (OTC Bulletin Board: MLSC - news) announced today that its pharmaceutical drug, MDI-P, has demonstrated potent anti-HIV activity. MDI-P has been shown to be effective in KILLIN HIV in cell culture. HIV is the virus that causes acquired immune deficiency syndrome (AIDS). These tests were conducted at a major National Institute of Health approved HIV research laboratory. It is the Company's intention to publish these data upon the completion of ongoing studies. These data confirm and validate nearly seven years of ongoing research and development on the ability of MDI-P to target the HIV virus. ''The importance of MDI-P is highlighted by the fact that it works on mechanisms which are different than those targeted by the currently approved anti-retroviral agents,'' stated MDI VP and Chief Technical Officer, William J. Novick, Ph.D. Experiments are ongoing to maximize the drug's efficacy. Medical Discoveries, Inc., intends to submit an Investigational New Drug application with the Food and Drug Administration upon the completion of certain additional testing currently in progress. Medical Discoveries, Inc. is a bio-pharmaceutical corporation focused on the research, development and commercialization of electrolysis based technologies targeted at anti-viral (HIV/AIDS), anti-bacterial, anti-fungal and other applications. SOURCE: Medical Discoveries, Inc. More Quotes and News: Medical Discoveries Inc (OTC BB:MLSC - news) Related News Categories: biotech, health care, medical/pharmaceutical